发明名称 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
摘要 <p>A recombinant Modified Vaccinia Ankara Virus (MVA) comprises a heterologous DNA sequence inserted into an intergenic region (IGR) of the viral genome. Also described is the use of the MVA for the preparation of a medicament and/or vaccine in the treatment and/or prophylaxis of a viral infection and/or proliferating disease, for example dengue virus infection or immunodeficiency virus infection, preferably HIV infection.</p>
申请公布号 NZ536501(A) 申请公布日期 2006.08.31
申请号 NZ20030536501 申请日期 2003.05.14
申请人 BAVARIAN NORDIC A/S 发明人 HOWLEY, PAUL;LEYRER, SONJA
分类号 C12N15/09;A61K35/36;A61K39/12;A61K39/21;A61K39/285;A61K39/29;A61K39/39;A61P1/16;A61P31/12;A61P31/14;A61P31/18;A61P31/20;A61P35/00;C07K14/07;C07K14/16;C07K14/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N15/863;C12P21/02;C12Q1/68;C12Q1/70;(IPC1-7):C12N15/863;A61K31/70;A61P37/00 主分类号 C12N15/09
代理机构 代理人
主权项
地址